Dear editor,

We researched the relevant studies about the association between the high-affinity IgE receptor β chain (*FcεRIβ*) polymorphisms and allergic diseases risk in Medline, Embase, Web of Science, Chinese National Knowledge Infrastructure, and Wanfang databases. No limit of start year and month was set, and the updated time was August 2019. The terms, search strategies, and inclusion/exclusion criteria were the same as reported by Guo et al. \[[@B1]\]. Comparing our retrieved studies with the ones in [Table 1](#T1){ref-type="table"} of Guo *et al*.'s paper \[[@B1]\], it seems that some errors or mistakes should be corrected.

###### Main characteristics of eligible studies

  Author                             Year   Country        Ethnicity   Atopy             Sample size (*n*)   Genotype frequency (*n*)   HWE (*P*)                               
  ---------------------------------- ------ -------------- ----------- ----------------- ------------------- -------------------------- ----------- ----- ---- ----- ----- ---- ---------
  *FcεRIβ* gene E237G polymorphism                                                                                                                                              
  Shirakawa                          1996   Japan          Asian       asthma            300                 100                        256         44    0    94    6     0    1.000
  Green                              1998   South Africa   African     asthma            41                  42                         27          12    2    25    17    0    0.172
  Green                              1998   South Africa   Caucasian   asthma            46                  51                         35          11    0    47    4     0    1.000
  Rohrbach                           1998   Switzerland    Caucasian   asthma            224                 159                        207         17    0    151   8     0    1.000
  Ishizawa                           1999   Japan          Asian       asthma            90                  102                        70          19    1    81    21    0    0.593
  Chen                               2000   China          Asian       asthma            101                 47                         59          39    3    30    16    1    1.000
  Soriano                            2000   Spain          Caucasian   asthma            145                 47                         134         11    0    43    4     0    1.000
  Takabayashi                        2000   Japan          Asian       asthma            100                 100                        69          27    4    65    33    2    1.000
  Nagata                             2001   Japan          Asian       rhinitis          233                 100                        150         76    7    77    18    5    0.021
  Zeng                               2001   China          Asian       asthma            69                  28                         61          5     3    27    1     0    1.000
  Cui                                2003   China          Asian       asthma            216                 198                        125         80    11   148   46    4    0.766
  Korzycka                           2004   Poland         Caucasian   asthma rhinitis   98                  87                         92          6     0    83    4     0    1.000
  Rigoli                             2004   Italy          Caucasian   asthma rhinitis   100                 103                        79          16    5    102   1     0    1.000
  Sharma                             2004   India          Asian       asthma            329                 266                        300         29    0    250   16    0    1.000
  Zhang (Chinese)                    2004   Singapore      Asian       asthma            141                 157                        81          57    3    108   42    7    1.194
  Zhang (Indian)                     2004   Singapore      Asian       asthma            82                  98                         71          10    1    80    18    0    1.000
  Zhang (Malay)                      2004   Singapore      Asian       asthma            68                  100                        49          19    0    77    23    0    0.353
  Zhao                               2004   China          Asian       asthma            151                 105                        126         23    2    92    13    0    1.000
  Kim                                2006   Korea          Asian       asthma            307                 264                        235         64    8    177   81    6    0.353
  Li                                 2006   China          Asian       asthma            50                  40                         43          7     0    40    0     0    1.000
  Liu                                2006   China          Asian       asthma            60                  50                         45          14    1    39    10    1    0.527
  Kim                                2009   Korea          Asian       asthma            347                 303                        244         99    4    217   81    5    0.409
  Wang                               2009   China          Asian       asthma            446                 506                        309         121   16   314   165   27   0.386
  Undarmaa                           2010   Japan          Asian       asthma            367                 630                        256         102   9    440   165   25   0.061
  Undarmaa                           2010   Japan          Asian       asthma            322                 336                        243         70    9    242   85    9    0.642
  Murk                               2011   U.S.A.         mixed       asthma            100                 486                        91          9     0    452   33    1    0.470
  Dmitrieva                          2012   Russia         Caucasian   asthma            224                 172                        217         7     0    170   2     0    1.000
  Ungvari                            2012   Hungary        Caucasian   asthma            436                 765                        418         17    1    723   38    4    0.004
  Zheng                              2012   China          Asian       asthma            198                 110                        126         61    11   76    29    5    0.325
  Chen                               2014   China          Asian       asthma            46                  52                         38          6     2    38    6     8    \<0.001
  Wan                                2014   China          Asian       asthma            58                  50                         41          16    1    47    3     0    1.000
  Ramphul                            2014   India          Asian       asthma            192                 188                        170         21    1    163   24    1    0.605
  Amo                                2016   Spain          Caucasian   rhinitis          366                 526                        330         36    0    487   39    0    1.000
  Amo                                2016   Spain          Caucasian   asthma rhinitis   149                 526                        146         3     0    487   39    0    1.000
  Hua                                2016   China          Asian       asthma            1000                1000                       659         276   65   688   289   23   0.252
  Yang                               2017   China          Asian       asthma            74                  110                        38          31    5    77    30    3    1.000

  Author                              Year   Country     Ethnicity   Atopy             Sample size (*n*)   Genotype frequency (*n*)   HWE (*P*)                                 
  ----------------------------------- ------ ----------- ----------- ----------------- ------------------- -------------------------- ----------- ----- ----- ----- ----- ----- -------
  *FcεRIβ* gene C-109T polymorphism                                                                                                                                             
  Dickson                             1999   Australia   Caucasian   asthma            44                  26                         11          17    16    6     15    5     0.428
  Cui                                 2003   China       Asian       asthma            216                 198                        23          106   87    19    103   76    0.059
  Gan                                 2004   China       Asian       asthma            45                  45                         10          12    23    12    14    19    0.015
  Zhao                                2004   China       Asian       asthma            126                 87                         11          69    46    9     38    40    0.996
  Hizawa                              2006   Japan       Asian       asthma            374                 374                        39          178   157   49    169   156   0.762
  Kim                                 2006   Korea       Asian       asthma            302                 264                        17          139   146   23    128   113   0.114
  Potaczek                            2007   Poland      Caucasian   asthma            154                 154                        25          72    57    27    70    57    0.495
  Kim                                 2009   Korea       Asian       asthma            346                 303                        20          167   159   28    135   140   0.576
  Sharma                              2009   India       Asian       asthma            237                 221                        89          108   40    34    118   69    0.156
  Tikhonova                           2010   Russia      Caucasian   asthma            140                 136                        18          69    53    18    70    48    0.339
  Ramphul                             2014   India       Asian       asthma            189                 188                        55          99    35    66    87    35    0.505
  Wan                                 2014   China       Asian       asthma            58                  50                         2           25    31    1     16    33    1.000
  Amo                                 2016   Spain       Caucasian   asthma rhinitis   366                 526                        78          188   100   105   277   144   0.176
  Amo                                 2016   Spain       Caucasian   rhinitis          149                 526                        35          67    47    105   277   144   0.176
  Hua                                 2016   China       Asian       asthma            1000                1000                       148         436   416   124   470   406   0.502

Abbreviation: HWE, Hardy--Weinberg equilibrium.

First, several relevant studies that met the inclusion criteria were missed in Guo *et al*.'s paper \[[@B2]\]. Of the 14 missed studies, 5 articles were published before January 2000 \[[@B2]\], which was the start time of published paper restricted in Guo *et al*.'s literature searching strategy \[[@B1]\]; 3 reports were from Japan \[[@B2],[@B6],[@B11]\], 4 studies were from China \[[@B9],[@B13]\], 1 each was from South Africa \[[@B3]\], Switzerland \[[@B4]\], Australia \[[@B5]\], India \[[@B7]\], South Korea \[[@B8]\], the U.S.A. \[[@B11]\], and Hungary \[[@B12]\], respectively. In Green *et al.*'s study, black and white populations were recruited, respectively \[[@B3]\]. In Undarmaa *et al.*'s report, children and adult populations were collected, respectively \[[@B10]\].

Second, several studies published by the same research group were included in Guo *et al*.'s report \[[@B1]\]. According to the inclusion and exclusion criteria, when more than two studies were reported by the same research group, only the paper with the largest sample size was included in the analysis. We think Cui *et al.*'s study \[[@B16]\], published in 2004, with 106 adult asthmatics and 106 controls, were incorporated into their another paper, published in 2003, with 216 (number including adults and children) cases and 198 controls \[[@B17]\]. Similarly, the study populations in Hua *et al.*'s papers \[[@B18],[@B19]\] and the Chinese Han case/control populations in Ramphul *et al.*'s article \[[@B20]\], were recruited by the same research group, the two smaller sample-size studies should be excluded from the analysis \[[@B18],[@B20]\].

Third, one study reported by Laprise *et al*. \[[@B21]\], with atopic/non-atopic contrast groups, not all the subjects in atopic group met with the diagnosis criteria of asthma, should be excluded from the analysis.

Fourth, the reported genotype frequency for the C-109T or E+237G polymorphisms of *FcεRIβ* gene in two studies of Guo *et al*.'s paper \[[@B1]\] were not in agreement with the ones in their original papers \[[@B22],[@B23]\]. In Sharma and Ghosh's study, the CC, CT, and TT genotype frequency for C-109T polymorphism in case/control groups were (89, 108, and 40)/(34, 118, and 69), respectively \[[@B22]\], which were wrongly counted as (87, 113, and 37)/(39, 108, and 74), respectively, in Guo *et al*.'s paper \[[@B1]\]. In Amo *et al*.'s published article, the EE, EG, and GG genotype frequency in control group for E+237G polymorphism were 487, 39, and 0, respectively \[[@B23]\], which were wrongly counted as 144, 277, and 105, respectively \[[@B1]\].

Considering the above-listed mistakes or errors in Guo *et al.*'s published paper, it seems that the findings and conclusions of Guo *et al.*'s study were not entirely reliable \[[@B1]\]. To overcome the limitations, we performed an updated meta-analysis to re-assess the associations of C-109T and E+237G polymorphisms in the *FcεRIβ* gene with allergic disease (asthma and allergic rhinitis) risk. The statistical analysis methods and software used in this comment were the same as reported by Guo *et al*., unless otherwise indicated \[[@B1]\].

The main characteristics of the eligible studies \[[@B2],[@B19],[@B20],[@B22]\], including the first author, publication year, country where individual study was conducted, ethnicity of study population, atopic disease category, sample size of case/control groups, the detailed genotype frequency, and the *P*-values for Hardy--Weinberg Equilibrium (HWE) test, were shown in [Table 1](#T1){ref-type="table"}. There were 36 case--control studies about the association between E+237G variant and allergic diseases risk \[[@B2],[@B6],[@B17],[@B19],[@B20],[@B23],[@B30],[@B36],[@B38],[@B39],[@B41],[@B42]\], and 15 were about the correlation of C-109T polymorphism with allergic diseases risk \[[@B5],[@B8],[@B12],[@B14],[@B17],[@B19],[@B22],[@B23],[@B29],[@B34],[@B35],[@B37],[@B38],[@B40]\]. Of the 15 case--control studies about C-109T polymorphism and allergic disease risk (14 ones according to ethnicity or HWE classification), 10 were performed in Asians \[[@B8],[@B14],[@B17],[@B19],[@B20],[@B22],[@B29],[@B34],[@B35],[@B38]\] and 4 were conducted in Caucasians \[[@B5],[@B23],[@B37],[@B40]\], respectively; 13 studies were about asthma risk \[[@B5],[@B8],[@B17],[@B19],[@B20],[@B22],[@B29],[@B34],[@B37],[@B38],[@B40]\], 1 was about allergic rhinitis risk \[[@B23]\], and 1 about asthma and rhinitis risk \[[@B23]\], respectively; genotype frequency distribution in control groups of 13 studies were in agreement with HWE \[[@B5],[@B8],[@B14],[@B17],[@B19],[@B20],[@B22],[@B23],[@B34],[@B35],[@B37],[@B38],[@B40]\] and 1 was not \[[@B29]\], respectively. Of the 36 case--control studies about E+237G variant with allergic diseases risk (35 ones according to ethnicity or HWE classification), 25 were carried out in Asians \[[@B2],[@B6],[@B13],[@B17],[@B19],[@B20],[@B24],[@B26],[@B32],[@B33],[@B36],[@B38],[@B39],[@B42]\], 8 were performed in Caucasians \[[@B3],[@B4],[@B12],[@B23],[@B25],[@B30],[@B31],[@B41]\], 1 in Africans \[[@B3]\] and 1 in mixed populations \[[@B11]\], respectively; 31 studies were about asthma risk \[[@B2],[@B6],[@B17],[@B19],[@B20],[@B24],[@B28],[@B29],[@B31],[@B36],[@B38],[@B39],[@B41],[@B42]\], 2 were on rhinitis risk \[[@B23],[@B27]\], and 3 were concerned with asthma/rhinitis risk \[[@B23],[@B30],[@B31]\], respectively; genotype frequency distribution in control groups of 32 studies were in line with HWE \[[@B2],[@B6],[@B13],[@B17],[@B19],[@B20],[@B23],[@B28],[@B36],[@B38],[@B39],[@B41],[@B42]\] and 3 were not \[[@B12],[@B13],[@B27]\], respectively.

[Table 2](#T2){ref-type="table"} listed the summary odds ratios (ORs) of the association of *FcεRIβ* C-109T polymorphism with allergic diseases risk. Overall, no significant associations between C-109T polymorphism and allergic diseases risk were observed (OR = 1.001, 95% confidence interval (CI): 0.909--1.102 for CC+CT vs. TT and OR = 1.015, 95% CI: 0.788--1.307 for CC vs. CT+TT, respectively). When subgroup analyses by ethnicity (Asian and Caucasian), allergic disease classification (asthma, rhinitis, and both) and HWE (in and not) were performed, we did not find any statistically significant associations of C-108T polymorphism with allergic diseases risk ([Table 2](#T2){ref-type="table"}). No any publication and other small study related biases were observed in overall and subgroup analyses ([Table 2](#T2){ref-type="table"}).

###### Summary ORs for the association between *FcεRIβ* C-109T polymorphism and allergic diseases risk

  Comparisons                                   Sample size   Number of studies   Hypothesis tests       Heterogeneity tests   Publication bias test (*P*)                                          
  --------------------------------------------- ------------- ------------------- ---------------------- --------------------- ----------------------------- ------------ --------- ------- ------- -------
  Overall                                                                                                                                                                                           
  C vs. T                                       7492/7144     14                  1.024 (0.900--1.164)   0.36                  0.722                         37.83 (13)   \<0.001   65.6    0.784   0.958
  CC vs. TT                                     1994/1862     14                  1.007 (0.759--1.335)   0.05                  0.963                         36.77 (13)   \<0.001   64.6    0.870   0.582
  CC vs. CT                                     2333/2231     14                  1.028 (0.807--1.311)   0.22                  0.823                         30.59 (13)   0.004     57.5    0.702   0.419
  CT vs. TT                                     3165/3051     14                  0.984 (0.890--1.089)   0.31                  0.758                         14.33 (13)   0.351     9.3     0.547   0.538
  CC+CT vs. TT                                  3746/3572     14                  1.001 (0.909--1.102)   0.01                  0.989                         21.72 (13)   0.060     40.1    0.784   0.670
  CC vs. CT+TT                                  3746/3572     14                  1.015 (0.788--1.307)   0.11                  0.911                         37.20 (13)   \<0.001   65.1    0.956   0.446
  Stratification by ethnicity                                                                                                                                                                       
  Asians                                                                                                                                                                                            
  C vs. T                                       5786/5460     10                  1.052 (0.883--1.254)   0.57                  0.567                         36.51 (9)    \<0.001   75.3    0.655   0.802
  CC+CT vs. TT                                  2893/2730     10                  1.070 (0.895--1.280)   0.74                  0.458                         18.97 (9)    0.025     52.6    0.325   0.304
  CC vs. CT+TT                                  2893/2730     10                  0.998 (0.695--1.434)   0.01                  0.992                         36.70 (9)    \<0.001   75.5    0.788   0.537
  Caucasians                                                                                                                                                                                        
  C vs. T                                       1706/1684     4                   0.984 (0.858--1.127)   0.24                  0.813                         0.89 (3)     0.828     \<0.1   0.042   0.036
  CC+CT vs. TT                                  853/842       4                   0.919 (0.747--1.130)   0.80                  0.422                         1.99 (3)     0.576     \<0.1   0.174   0.201
  CC vs. CT+TT                                  853/842       4                   1.067 (0.836--1.362)   0.52                  0.601                         0.48 (3)     0.924     \<0.1   1.000   0.412
  Stratification by atopic disease categories                                                                                                                                                       
  Asthma                                                                                                                                                                                            
  C vs. T                                       6462/6092     13                  1.024 (0.885--1.185)   0.32                  0.750                         37.83 (12)   \<0.001   68.3    0.903   0.950
  CC+CT vs. TT                                  3231/3046     13                  1.032 (0.883--1.207)   0.40                  0.691                         21.52 (12)   0.043     44.2    1.000   0.712
  CC vs. CT+TT                                  3231/3046     13                  0.997 (0.744--1.336)   0.02                  0.983                         37.13 (12)   \<0.001   67.7    0.542   0.472
  Stratification by HWE                                                                                                                                                                             
  C vs. T                                       7402/7054     13                  1.035 (0.907--1.180)   0.51                  0.613                         36.83 (12)   \<0.001   67.4    1.000   0.861
  CC+CT vs. TT                                  3701/3527     13                  1.006 (0.913--1.108)   0.11                  0.911                         21.00 (12)   0.050     42.9    0.272   0.483
  CC vs. CT+TT                                  3701/3527     13                  1.026 (0.789--1.335)   0.19                  0.848                         36.76 (12)   \<0.001   67.4    0.807   0.516

Abbreviation: df, degree of freedom.

[Table 3](#T3){ref-type="table"} showed the summary ORs for the association between *FcεRIβ* E237G variant and allergic diseases risk. Overall, we observed *FcεRIβ* 237G allele was associated with increased risk of allergic diseases in total population (OR = 1.178, 95% CI: 1.022--1.357 for G vs. E and OR = 1.207, 95% CI: 1.031--1.411 for GG+EG vs. EE, respectively) ([Table 3](#T3){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}). When restricted the analysis to the studies with control groups' genotype frequency distribution were met with HWE, we observed an elevated risk of allergic diseases among subjects carrying EG or GG genotypes, in comparison with EE genotype carriers (OR = 1.225, 95% CI: 1.041--1.442) ([Table 3](#T3){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}). When stratified analyses were conducted by ethnicity, we found an increased risk of allergic diseases in subjects carrying EG or GG genotypes, compared with EE genotype carries in Asians (OR = 1.189, 95% CI: 1.001--1.412) ([Table 3](#T3){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}). No significant association of E237G polymorphism with allergic diseases risk was observed in Caucasians (OR = 1.544, 95% CI: 0.884--2.697 for G allele vs. E allele and OR = 1.547, 95% CI: 0.895--2.673 for EG+GG vs. EE, respectively) ([Table 3](#T3){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}). In subgroup analyses by allergic diseases classification (asthma, allergic rhinitis, and both), we did not observe significant association of E237G with any allergic diseases categories ([Table 3](#T3){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}).
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###### Summary ORs for the association between *FcεRIβ* E273G polymorphism and allergic diseases risk

  Comparisons                                   Sample size   Number of studies   Hypothesis tests        Heterogeneity tests   Publication bias test (*P*)                                         
  --------------------------------------------- ------------- ------------------- ----------------------- --------------------- ----------------------------- ------------ --------- ------ ------- -------
  Overall                                                                                                                                                                                           
  G vs. E                                       14552/14956   35                  1.178 (1.022--1.357)    2.25                  0.024                         84.83 (34)   \<0.001   59.9   0.028   0.025
  GG+GE vs. EE                                  7276/7478     35                  1.207 (1.031--1.411)    2.35                  0.019                         82.95 (34)   \<0.001   59.0   0.024   0.008
  Stratification by ethnicity                                                                                                                                                                       
  Asians                                                                                                                                                                                            
  G vs. E                                       10694/10080   25                  1.158 (0.994--1.350)    1.88                  0.060                         65.83 (24)   \<0.001   63.5   0.176   0.122
  GG+GE vs. EE                                  5347/5040     25                  1.189 (1.001--1.412)    1.98                  0.048                         64.41 (24)   \<0.001   62.7   0.148   0.046
  Caucasians                                                                                                                                                                                        
  G vs. E                                       3576/3820     8                   1.544 (0.884--2.697)    1.53                  0.126                         19.63 (7)    0.006     64.3   0.026   0.028
  GG+GE vs. EE                                  1788/1910     8                   1.547 (0.895--2.673)    1.56                  0.118                         18.02 (7)    0.012     61.1   0.026   0.028
  Stratification by atopic disease categories                                                                                                                                                       
  Asthma                                                                                                                                                                                            
  G vs. E                                       12660/13324   31                  1.148 (0.994--1.326)    1.88                  0.060                         72.22 (30)   \<0.001   58.5   0.051   0.081
  GG+GE vs. EE                                  6330/6662     31                  1.164 (0.994--1.364)    1.89                  0.059                         69.11 (30)   \<0.001   56.6   0.047   0.031
  Allergic rhinitis                                                                                                                                                                                 
  G vs. E                                       764/1252      2                   0.680 (0.124--3.737)    0.44                  0.657                         7.30 (1)     0.007     86.3   0.317   \-
  GG+GE vs. EE                                  382/626       2                   0.740 (0.103--5.324)    0.30                  0.765                         9.20 (1)     0.002     89.1   0.317   \-
  Asthma and/or allergic rhinitis                                                                                                                                                                   
  G vs. E                                       1128/1432     3                   2.955 (0.616--14.181)   1.35                  0.176                         10.60 (2)    0.005     81.1   0.117   0.449
  GG+GE vs. EE                                  564/716       3                   2.796 (0.646--12.109)   1.37                  0.169                         9.01 (2)     0.011     77.8   0.117   0.451
  Stratification by HWE                                                                                                                                                                             
  Yes                                                                                                                                                                                               
  G vs. E                                       13122/13122   32                  1.211 (1.046--1.403)    2.55                  0.011                         76.29 (31)   \<0.001   59.4   0.009   0.008
  GG+GE vs. EE                                  6561/6561     32                  1.225 (1.041--1.442)    2.44                  0.015                         75.76 (31)   \<0.001   59.1   0.011   0.004

Abbreviation: df, degree of freedom.

We also performed a cumulative meta-analysis which accumulated the evidence about association of E237G variant with allergic diseases risk in the order of publication year of individual study. We observed that the association of EG/GG genotypes with increased allergic diseases started to become significant for the first time when Zeng *et al.*'s \[[@B28]\] study published in the year of 2001 (OR = 1.374, 95% CI: 1.013--1.864) and the summary OR became very similar to the OR estimated in this report (OR = 1.207) when Wang *et al.*'s \[[@B39]\] study published in the year of 2009 (OR = 1.299, 95% CI: 1.026--1.644) ([Figure 4](#F4){ref-type="fig"}).The overall tendency of summary OR variation seemed alarming at the top of forest plot of the cumulative meta-analysis. It should be noted that Shirakawa *et al*. \[[@B2]\] (study 1) reported the first positive association of 237EG+GG with asthma risk with OR being equal to 2.693 in a Japanese (Asian) population and the second included study \[[@B3]\] with two independent case--control studies \[one in black (study 2) and one in white (study 3)\] reported different associations, one is negative association of 237EG+GG with asthma risk in Black (OR = 0.763) and the other is similar to Shirakawa *et al*.'s result in White population (OR = 3.693). When merging the result of study 1 with study 2, the overall OR significantly decreased. And when summarizing the results of the first three studies (*i.e.* study 1, 2, and 3) the overall OR looked bigger than the second. As a result, the overall ORs would generate a V-form change in the forest plot of cumulative meta-analysis. The alarming changes in the plot of cumulative meta-analysis also indicated that there was high heterogeneity of the results of the included individual studies.
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Sensitivity analysis was performed by sequentially omitting each individual study in the order of publication year and the pooled ORs were estimated repeatedly, which was used to evaluate the stability of the results of present meta-analysis. The sensitivity analysis showed that the association of EG and GG genotypes with increased risk of allergic diseases maintained statistically significant when removing any each individual study ([Figure 5](#F5){ref-type="fig"}). Egger's regression test and Begg's rank correlation test were used to evaluate the small-study effects and potential publication bias in current meta-analysis. Both tests indicated that the significant association of G allele or EG+GG genotypes with elevated risk of allergic diseases might strongly influenced by small-study effect or publication bias ([Table 3](#T3){ref-type="table"}). The Egger's funnel plots for the association between E237G polymorphism and allergic diseases risk also showed that the OR distributions for both G allele vs. E allele ([Figure 6](#F6){ref-type="fig"}A) and EG+GG vs.EE ([Figure 6](#F6){ref-type="fig"}B) were obviously asymmetrical.
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![Egger's funnel plots for the association between FcεRIβ E237G polymorphism and allergic diseases risk\
(**A**) G allele vs. E allele; (**B**) EG/GG genotypes vs. EE genotype.](bsr-40-bsr20193424-g6){#F6}

There are some inherent limitations of meta-analysis which should be taken into consideration when using the results of this comment. First, there was high heterogeneity in this meta-analysis, especially in the case of association of E237G variant with allergic diseases risk. Although, subgroup analyses were performed on the basis of ethnicity, allergic disease category and HWE, heterogeneity among the included studies still be statistically significant in all subgroups. Second, publication bias tests indicated that the probable existence of publication bias, i.e*.* some unpublished negative results studies thus could not be included in this analyses might result in an over-estimated association of E237G with allergic disease risk.

In conclusion, the results of Guo et al*.*'s study \[[@B1]\] should be interpreted with caution. To make an asserted conclusion, well-designed studies with large number of homogeneous population are required. We do hope that this comment will be helpful to clarify the results presented by Guo et al. \[[@B1]\].
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